Wednesday 19 January 2022

Another 2.4% loss overall. OncoSec hit with a double digit loss


Another 2.4% loss overall as brutality continues. OncoSec let on the downside with another 10% hit. It has had a not bad couple of weeks after a disastrous year.

Moderna and Ocugen fell 7%, while Novavax fell 6%, Vir tumbled 5% and with BioNTech not far behind fall 4.5%. 

There were only two gainers and three others that did nothing -- a major win in this hellscape.


 

No comments:

Post a Comment